Hoppa till innehållet
AegirBio CEO, Marco Witteveen, recently conducted an interview in Stockholm on the company's current position and strategic outlook.
During the interview, Mr. Witteveen emphasized the pivotal juncture the company finds itself in, asserting that the leadership team has a clear vision of the path ahead. The company is set on a course focused on the market opportunities in Therapeutic Drug Monitoring and Oral Health. These areas, he stressed, not only hold significant clinical, operational, and economic potential but also promise to enhance the offerings available in today's market.
Mr. Witteveen underscored the combination of in-house expertise and unwavering drive that propels the company forward. Additionally, he highlighted the robust organizational culture that has been nurtured within the company, one that resonates with both our team members and the broader market. This unique blend of factors, complemented by a strategic public relations approach, positions us in the market.
We believe that this interview encapsulates the essence of our company's strategic vision and reinforces our commitment to delivering innovative solutions that create substantial value in the healthcare industry. Please check the link,https://youtu.be/hFKDMHbCmoE, for the full interview